Article info
PDFCommentary
Using open notes to advance nocebo research: challenges and opportunities
- Correspondence to Dr Marco Annoni, Interdepartmental Center for Research Ethics and Integrity, National Research Council of Italy, Rome, Italy; marco.annoni{at}cnr.it
Citation
Using open notes to advance nocebo research: challenges and opportunities
Publication history
- Received November 14, 2022
- Accepted November 16, 2022
- First published November 24, 2022.
Online issue publication
December 19, 2022
Article Versions
- Previous version (19 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Sharing online clinical notes with patients: implications for nocebo effects and health equity
- Open notes in patient care: confining deceptive placebos to the past?
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Unethical informed consent caused by overlooking poorly measured nocebo effects
- How factual do we want the facts? Criteria for a critical appraisal of empirical research for use in ethics
- Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
- Old problems in need of new (narrative) approaches? A young physician–bioethicist’s search for ethical guidance in the practice of physician-assisted dying in the Netherlands
- Digital bioethics: introducing new methods for the study of bioethical issues
- Response to commentaries on sharing online clinical notes with patients: implications for nocebo effects and health equity
- Is there a nocebo response that results from disease awareness campaigns and advertising in Australia, and can this effect be mitigated?